The global nebulizer devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of respiratory diseases such as COPD and asthma, which are major drivers for the growth of this market. The increasing awareness about these diseases and their treatment methods is also driving the growth of this market.
The global nebulizer devices market by type is segmented into pneumatic nebulizers, ultrasonic nebulizers, and mesh nebulizers. Pneumatic nebulizers are expected to account for a significant share in the global nebulizer devices market during the forecast period due to their low cost and ease-of-use features. Ultrasonic nebulizers are expected to witness significant growth in terms of revenue due to their high efficiency in generating aerosols with less power consumption than pneumatic or mesh type devices. Mesh type devices are expected to witness moderate growth during the forecast period owing to its ability in generating aerosols with higher particle size distribution than other types of device.
Nebulizer devices are used to deliver medication in the form of a mist. Nebulizers are often used for people with asthma, COPD, cystic fibrosis and other lung diseases.
Industry Growth Insights published a new data on “Nebulizer Devices Market”. The research report is titled “Nebulizer Devices Market research by Types (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Applications (COPD, Cystic Fibrosis, Asthma, Others), By Players/Companies PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Agilent Technologies, Allied Healthcare Products, CareFusion Corporation, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nebulizer Devices Market Research Report
By Type
Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer
By Application
COPD, Cystic Fibrosis, Asthma, Others
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Agilent Technologies, Allied Healthcare Products, CareFusion Corporation, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Nebulizer Devices Market Report Segments:
The global Nebulizer Devices market is segmented on the basis of:
Types
Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COPD, Cystic Fibrosis, Asthma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips
- Agilent Technologies
- Allied Healthcare Products
- CareFusion Corporation
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- 3A Health Care
- Trudell Medical International
- GF Health Products
Highlights of The Nebulizer Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pneumatic Nebulizer
- Ultrasonic Nebulizer
- Mesh Nebulizer
- By Application:
- COPD
- Cystic Fibrosis
- Asthma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nebulizer Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Nebulizer is a device that helps to break down and remove toxins from the lungs.
Some of the major players in the nebulizer devices market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Agilent Technologies, Allied Healthcare Products, CareFusion Corporation, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products.
The nebulizer devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nebulizer Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nebulizer Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nebulizer Devices Market - Supply Chain
4.5. Global Nebulizer Devices Market Forecast
4.5.1. Nebulizer Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nebulizer Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nebulizer Devices Market Absolute $ Opportunity
5. Global Nebulizer Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nebulizer Devices Market Size and Volume Forecast by Type
5.3.1. Pneumatic Nebulizer
5.3.2. Ultrasonic Nebulizer
5.3.3. Mesh Nebulizer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nebulizer Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nebulizer Devices Market Size and Volume Forecast by Application
6.3.1. COPD
6.3.2. Cystic Fibrosis
6.3.3. Asthma
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nebulizer Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nebulizer Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nebulizer Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nebulizer Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nebulizer Devices Demand Share Forecast, 2019-2026
9. North America Nebulizer Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nebulizer Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nebulizer Devices Market Size and Volume Forecast by Application
9.4.1. COPD
9.4.2. Cystic Fibrosis
9.4.3. Asthma
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nebulizer Devices Market Size and Volume Forecast by Type
9.7.1. Pneumatic Nebulizer
9.7.2. Ultrasonic Nebulizer
9.7.3. Mesh Nebulizer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nebulizer Devices Demand Share Forecast, 2019-2026
10. Latin America Nebulizer Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nebulizer Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nebulizer Devices Market Size and Volume Forecast by Application
10.4.1. COPD
10.4.2. Cystic Fibrosis
10.4.3. Asthma
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nebulizer Devices Market Size and Volume Forecast by Type
10.7.1. Pneumatic Nebulizer
10.7.2. Ultrasonic Nebulizer
10.7.3. Mesh Nebulizer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nebulizer Devices Demand Share Forecast, 2019-2026
11. Europe Nebulizer Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nebulizer Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nebulizer Devices Market Size and Volume Forecast by Application
11.4.1. COPD
11.4.2. Cystic Fibrosis
11.4.3. Asthma
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nebulizer Devices Market Size and Volume Forecast by Type
11.7.1. Pneumatic Nebulizer
11.7.2. Ultrasonic Nebulizer
11.7.3. Mesh Nebulizer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. arket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nebulizer Devices Demand Share, 2019-2026
12. Asia Pacific Nebulizer Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nebulizer Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nebulizer Devices Market Size and Volume Forecast by Application
12.4.1. COPD
12.4.2. Cystic Fibrosis
12.4.3. Asthma
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nebulizer Devices Market Size and Volume Forecast by Type
12.7.1. Pneumatic Nebulizer
12.7.2. Ultrasonic Nebulizer
12.7.3. Mesh Nebulizer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nebulizer Devices Demand Share, 2019-2026
13. Middle East & Africa Nebulizer Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nebulizer Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nebulizer Devices Market Size and Volume Forecast by Application
13.4.1. COPD
13.4.2. Cystic Fibrosis
13.4.3. Asthma
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nebulizer Devices Market Size and Volume Forecast by Type
13.7.1. Pneumatic Nebulizer
13.7.2. Ultrasonic Nebulizer
13.7.3. Mesh Nebulizer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nebulizer Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nebulizer Devices Market: Market Share Analysis
14.2. Nebulizer Devices Distributors and Customers
14.3. Nebulizer Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. PARI GmbH
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Omron
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Drive DeVilbiss Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Philips
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Allied Healthcare Products
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CareFusion Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Yuwell
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Leyi
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Folee
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medel S.p.A
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Briggs Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. 3A Health Care
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Trudell Medical International
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. GF Health Products
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
